D. Keith Grossman

(Mr. D. Keith Grossman)

Currently holds positions in Outset Medical Inc, ViewRay Inc, Bayer Essure Inc and Alcon AG

Performance

Average Return

-12.5%

30 Days

8.2%

90 Days

15.1%

120 Days
Success Rate

50%

30 Days

68%

90 Days

82%

120 Days

Positions

Position Company Period
Chairman of the Board Outset Medical Inc None -
Independent Director ViewRay Inc July 1, 2018 -
President, Chief Executive Officer Bayer Essure Inc June 5, 2013 -
Vice Chairman of the Board, Senior Independent Director Alcon AG None -
Lead Independent Director ZELTIQ Aesthetics Inc Feb. 1, 2016 - April 28, 2017
Independent Director ZELTIQ Aesthetics Inc Oct. 24, 2013 - Feb. 1, 2016
President, Chief Executive Officer, Director Thoratec Corp Sept. 22, 2014 - Oct. 8, 2015
Independent Director Thoratec Corp Jan. 17, 2006 - Sept. 22, 2014
President, Chief Executive Officer, Director Bayer Essure Inc Dec. 8, 2011 - June 5, 2013
D. Keith Grossman's trades of Outset Medical Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-03 2024-06-03
PS Planned sale
11,887 -13.8%
3.74
USD 44,468 		11,887 -13.8% 3.74 USD 44,468
2024-06-03 2024-06-03
PS Planned sale
26,230 -35.4%
3.80
USD 99,766 		26,230 -35.4% 3.80 USD 99,766
2022-03-08 2022-03-08
US Nevro Corp (NVRO)
B Purchase
3,200 +1.9%
63.59
USD 203,488 		3,200 +1.9% 63.59 USD 203,488
2021-12-02 2021-12-01
PS Planned sale
1,296 -20.0%
47.92
USD 62,104 		1,296 -20.0% 47.92 USD 62,104
2021-11-02 2021-11-01
PS Planned sale
1,296 -16.7%
54.31
USD 70,386 		1,296 -16.7% 54.31 USD 70,386
2021-11-02 2021-11-01
PS Planned sale
2,592 -25.0%
55.00
USD 142,560 		2,592 -25.0% 55.00 USD 142,560
2021-10-04 2021-10-01
PS Planned sale
1,234 -37.5%
49.69
USD 61,317 		1,234 -37.5% 49.69 USD 61,317
2021-10-04 2021-10-01
PS Planned sale
62 -1.9%
49.69
USD 3,081 		62 -1.9% 49.69 USD 3,081
2021-10-04 2021-09-17
PS Planned sale
1,296 -28.3%
55.00
USD 71,280 		1,296 -28.3% 55.00 USD 71,280
2021-10-04 2021-09-17
PS Planned sale
1,296 -28.3%
55.00
USD 71,280 		1,296 -28.3% 55.00 USD 71,280
2021-10-04 2021-09-17
PS Planned sale
1,296 -28.3%
55.00
USD 71,280 		1,296 -28.3% 55.00 USD 71,280
2021-10-04 2021-09-17
PS Planned sale
1,296 -28.3%
55.00
USD 71,280 		1,296 -28.3% 55.00 USD 71,280
2021-08-17 2021-08-13
US Nevro Corp (NVRO)
B Purchase
7,000 +5.9%
105.07
USD 735,490 		7,000 +5.9% 105.07 USD 735,490
2021-06-02 2021-06-01
PS Planned sale
1,296 -100.0%
47.92
USD 62,102 		1,296 -100.0% 47.92 USD 62,102
// ... existing code ...